Tempus AI (TEM) stock

AI healthcare tests , market cap $13B

AI tests and a platform for healthcare data

Worth $13B

$80.54

-4.62%

As of Tuesday's close · Live for Pro members at the open

Why is TEM down?

Down 4.6% today, more than its software peers' 1.3%; no story names it yet.

Rose 14% since Nov 5

Up 14% from Nov 5 to Nov 10.

Tempus AI rose 14% from Nov 5 to Nov 10. 12 points of it came on Nov 9.

Sources: Price history, Nov 10, 2026

Tell me next time TEM moves

Free account, no card. An optional alert when TEM moves or its score changes.

Or see it live, free until Thursday morning. No account.

1 more reason, free with an account →1 more reason why TEM rose 14% since Nov 5, from its filings, with how the business stands, the timeline, and its peers, for Pro members.

Quality Score

Average

In its industry

#74of 268

Software

Checks firing

5of 14

Trending up

From 52-week high

-9.6%

under its best in a year

TEM's Quality Score fell 1 point on Tue, Nov 10, to 10. It closed away from its high of the day (2 chart checks stopped).

See TEM's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on TEM

Key facts on TEM
The company	Sales up 37% on the year
Latest filing	8-K, Nov 2 Reported its quarterly results

1 more reason behind TEM's 10, free with an account →7 more reasons behind TEM's 10, for Pro members.

TEM in the news

TodayNo story names it yet.

TEM catalysts

Coming up

After its last 4 reports it closed -0.2% on average, higher 1 of 4 times.

18 past catalysts since 2024, with sizes and sources, for Pro members.

Why TEM scores 10

Averagefor quality, not price, 5 of 14 chart checks firingWhat the Quality Score means

Well above its recent run. TEM scores 10 today, against a median of 5 over its last 20 recorded sessions.

+5Chart checks 5 of 14 firing right now, one point each
+3Long-term trend above a rising 200-⁠day average, near its 52-⁠week high

Run-up adds
Size adds
Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
Volatility subtractsA daily range of 5% or more with nothing behind it (no profit or cash flow, sales shrinking, or 10% more shares outstanding with no free cash flow): -1, or -2 from 8%.
Cash flow subtracts-1 when free cash flow over the last four quarters is negative.
News adds
Insider trades subtracts

No effect today: Dilution and Persistence.

What every line is worth, and the reason behind it, on TEM and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 11:29 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

How TEM ranks in Software

TEM is #74 of 268 by Quality Score.

How TEM ranks in Software
Rank	Stock	Checks	Quality Score
1	HNGEHinge Health	9/14	21
2	ZETAZeta Global	8/14	20
3	VEEVVeeva Systems	7/14	19
	TDCTeradata		Open for its score
	TEAMAtlassian		Open for its score
	TENBTenable		Open for its score
	TLSTelos		Open for its score
74	TEMTempus AI	5/14	10

When does TEM report earnings, and what happens after?

Expected to report Tue Feb 23, before the open (in 105 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What TEM reported on Nov 2, 2026

The quarter

Sales of $411.5M, 23% more than a year ago; a loss of $0.08 a share, from $0.46.

“Diagnostics generated $303.5 million of revenue, representing 20% growth, driven by Oncology volume growth of 32%, offset by Hereditary revenue growth of 3%.”

The quarter that ended Sep 30, from the company's press release

The press release The filing on EDGAR

Where the sales came from

Where the quarter's sales came from
Line	Q3 2026	Q2 2026	Q3 2025
By product
Diagnosticsup 20%	$303M74%	$289M76%	$253M76%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 2)

4 more lines, for Pro members.

The outlook

The outlook the company gave, by period
Measure	Figure
Full year 2026
Revenue	$1.600B to $1.605Braised

Figures as filed (SEC filing, Nov 2)

1 more outlook line, for Pro members.

The numbers

Market value: $13B; today
Sales: $1.5B; up 36.6% on the year
Free cash flow: -$137M; last 12 months

Sales grew 58% a year over 3 years, fiscal 2022 to 2025.

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on TEM: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-1.1%-0.9%+8.7%

May 5Jul 30Nov 2

Reported	When	Gap	Reaction	5 days
Nov 2, 2026Before open	Before open	+3.1%	+8.7%	+5.3%
Jul 30, 2026After close	After close	+4.4%	-0.9%	+4.1%
May 5, 2026After close	After close	-6.0%	-1.1%	-13.2%

TEM closed higher after 1 of its last 4 reports.

All 4 reports, and TEM's Quality Score going into each

TEM sales and profit by year

Sales and profit by year

Sales grew every year from 2022 to 2025, to $1.3B. It lost money in each of the four years.

TEM has 5 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on TEM, and all 14 on every stock.Get in free →

TEM RSI today: 57.2, above its 50-day and 200-day averages

Not scored

RSI 57.2, MACD above signal, above both averages. Not scored.13 readings

The deep dive on TEM

What it does and how it makes money4 findingsAn operating loss of $253M in fiscal 2025, on $1.27B of sales.Annual report, filed Feb 24, 2026"Our issued patents are expected to begin expiring in 2033, assuming payment of all appropriate maintenance, renewal, annuity or other governmental fees." (10-K for fiscal 2025)SEC filing · Feb 24, 2026
Where it stands3 findingsFor Pro members3 findings on where TEM stands: its cash, debt, and share count, for Pro members
What changed in its filings3 findings"On February 12, 2026, a lawsuit was filed against us in the United States District Court for the Northern District of Illinois." (10-Q for the quarter to Sep 30, 2026)SEC filing · Nov 2, 2026
Who holds and trades it3 findingsFor Pro members3 findings on who holds and trades TEM, for Pro members

10 more findings on TEM, each with its source, for Pro members.

TEM insider trades

6 insiders sold $11.6M across 9 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellEric P. Lefkofsky$6.6MCEO and Chairmanat $49.61 on Aug 18, filed Aug 20

SellEric P. LefkofskyCEO and Chairman$6.6Mat $49.61 on Aug 18, filed Aug 20

All 9 insider filings on TEM from the last six months, for Pro members.

All TEM insider trades

TEM trades by Congress and the executive branch

2 trades disclosed in the last six months. The newest:

SellDonald Trump$15K to $50KPresident (R)traded Jul 27, disclosed Sep 22(57 days later)

SellDonald TrumpPresident (R)$15K to $50Ktraded Jul 27, disclosed Sep 22(57 days later)

All 2 trades on TEM disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

TEM's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Eric P. LefkofskyCEO and Chairman · 18 trades
James William RogersChief Financial Officer · 9 trades
Ryan FukushimaCEO, Data · 15 trades
Andrew PolovinEVP, Chief Legal Officer · 9 trades
Ryan M. BartolucciChief Accounting Officer · 6 trades
Thomas Edward SchoenherrCEO, Diagnostics · 5 trades
Erik PhelpsEVP, Chief Admin. Officer · 4 trades
David R. EpsteinDirector · 7 trades

7 more officers and directors file at TEM.

See insider trades by person

Which ETFs hold TEM?

In ETFs: TEM is under 0.1% of SCHG and under 0.1% of VTI, the most of the 24 funds Breakaway covers, by each fund's latest filing, Jun 30 to Aug 31, 2026.

About Tempus AI

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

3,800 employeesChicago, ILtempus.com

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on TEM and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would move TEM's score: 6 things
3 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayJul 1Donald Trump bought TEM$15K to $50K, disclosed Jul 1

Alerts are optional.

See TEM's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: TEM's Quality Score is 10 (Average), #74 of 268 in Software. Insiders sold $11.6M in the last 6 months (Form 4).

What does TEM's Quality Score say?

TEM scores 10 today, which Breakaway calls Average. It is #74 of 268 in Software by Quality Score, with 5 of 14 chart checks firing. Up 14% from Nov 5 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is TEM's Quality Score?

TEM scores 10 today, which Breakaway calls Average (6 to 10). That is #74 of 268 in Software by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind TEM's 10.

Are insiders buying TEM?

6 insiders sold $11.6M across 9 filings in the last 6 months. No open-⁠market buys on record. The newest is Eric P. Lefkofsky, CEO and Chairman, who sold $6.6M on Aug 18. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.